From: The effect of HER2 expression on cisplatin-based chemotherapy in advanced non-small cell lung cancer patients
HER 2
CR+PR+SD
PD
HER 2 (+)
13 (63.9)
8(38.1%)
HER 2 (-)
48 (92.3%)
4(7.7%)
